Cargando…

A factor analysis of posttraumatic stress disorder symptoms using data pooled from two venlafaxine extended-release clinical trials

BACKGROUND: Confirmatory factor analysis (CFA) of Diagnostic and Statistical Manual of Mental Disorders (Fourth Edition) (DSM-IV) three-factor posttraumatic stress disorder (PTSD) diagnostic criteria was conducted to determine fit for this patient population. An exploratory factor analysis (EFA) of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Stein, Dan J, Rothbaum, Barbara O, Baldwin, David S, Szumski, Annette, Pedersen, Ronald, Davidson, Jonathan R T
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Blackwell Publishing Inc 2013
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3868178/ https://www.ncbi.nlm.nih.gov/pubmed/24363976 http://dx.doi.org/10.1002/brb3.183

Ejemplares similares

Venlafaxine extended release (XR) in the treatment of panic disorder
por: Kjernisted, Kevin, et al.
Publicado: (2007)

Efficacy of venlafaxine extended release in major depressive disorder patients: effect of baseline anxiety symptom severity
por: Lyndon, Gavin J., et al.
Publicado: (2019)

Venlafaxine-induced psychotic symptoms
por: Safeekh, A. T., et al.
Publicado: (2009)

Short-term efficacy and tolerability of venlafaxine extended release in adults with generalized anxiety disorder without depression: A meta-analysis
por: Li, Xinyuan, et al.
Publicado: (2017)

Venlafaxine in the treatment of panic disorder
por: Katzman, Martin A, et al.
Publicado: (2007)

Assessing Treatment-Resistant Posttraumatic Stress Disorder: The Emory Treatment Resistance Interview for PTSD (E-TRIP)
por: Dunlop, Boadie W., et al.
Publicado: (2014)

An Open-Label Investigation of the Pharmacokinetic Profiles of Lisdexamfetamine Dimesylate and Venlafaxine Extended-Release, Administered Alone and in Combination, in Healthy Adults
por: Ermer, James, et al.
Publicado: (2013)

Feasibility of Identifying Eligible Trauma Patients for Posttraumatic Stress Disorder Intervention
por: Malcoun, Emily, et al.
Publicado: (2010)

Formulation and evaluation of bilayer tablet for bimodal release of venlafaxine hydrochloride
por: Momin, Munira M., et al.
Publicado: (2015)

Symptoms of delusion: the effects of discontinuation of low-dose venlafaxine
por: Koga, M, et al.
Publicado: (2009)

A randomized, double-blind study comparing the efficacy and safety of trazodone once-a-day and venlafaxine extended-release for the treatment of patients with major depressive disorder
por: Fagiolini, Andrea, et al.
Publicado: (2020)

Modulation of Venlafaxine Hydrochloride Release from Press Coated Matrix Tablet
por: Gohel, M. C., et al.
Publicado: (2008)

Statistical Optimization of Sustained Release Venlafaxine HCI Wax Matrix Tablet
por: Bhalekar, M. R., et al.
Publicado: (2008)

Development of Obsessive-Compulsive Symptoms Following Abrupt Discontinuation of Venlafaxine
por: Gahr, Maximilian, et al.
Publicado: (2020)

Apathy symptoms induced by low‐dose venlafaxine: Two cases
por: Sato, Shinji, et al.
Publicado: (2020)

Development and validation of stability indicating method for the quantitative determination of venlafaxine hydrochloride in extended release formulation using high performance liquid chromatography
por: Kaur, Jaspreet, et al.
Publicado: (2010)

VENLAFAXINE-INDUCED MANIA
por: Jagadheesan, K., et al.
Publicado: (2001)

Venlafaxine besylate monohydrate
por: Corvalan, Carolina H., et al.
Publicado: (2013)

Kleptomania Induced by Venlafaxine
por: Sakurada, Kumi, et al.
Publicado: (2021)

Venlafaxine-induced hypoglycemia
por: Kobylianskii, Jane, et al.
Publicado: (2021)

Clinical and Neuropsychological Predictors of Posttraumatic Stress Disorder
por: Suliman, Sharain, et al.
Publicado: (2014)

Fabrication and characterization of electrospun nanofibers using biocompatible polymers for the sustained release of venlafaxine
por: Hashem, Heba M., et al.
Publicado: (2022)

Evaluation of a corticotropin releasing hormone type 1 receptor antagonist in women with posttraumatic stress disorder: study protocol for a randomized controlled trial
por: Dunlop, Boadie W, et al.
Publicado: (2014)

Pharmacoeconomic evaluation of venlafaxine compared with citalopram in generalized anxiety disorder
por: ZHANG, JINGJING, et al.
Publicado: (2013)

Persistant genital arousal disorder and venlafaxine: A case report
por: Marguilho, M., et al.
Publicado: (2021)

A randomized, double-blinded, placebo-controlled study to evaluate the efficacy and safety of venlafaxine extended release and a long-term extension study for patients with major depressive disorder in Japan
por: Higuchi, Teruhiko, et al.
Publicado: (2016)

Rumination, posttraumatic stress disorder, and mood symptoms in borderline personality disorder
por: Dell’Osso, Liliana, et al.
Publicado: (2019)

VENLAFAXINE - INDUCED ORTHOSTATIC HYPOTENSION
por: Duggal, Harpreet S., et al.
Publicado: (2001)

Antidepressant therapy with milnacipran and venlafaxine
por: Mansuy, Lucilla
Publicado: (2010)

Structural Connectivity of the Posterior Cingulum Is Related to Reexperiencing Symptoms in Posttraumatic Stress Disorder
por: Weis, Carissa N., et al.
Publicado: (2018)

Predicting posttraumatic stress and depression symptoms among adolescents in the extended postpartum period
por: Anderson, Cheryl A., et al.
Publicado: (2018)

Formulation and Optimization of Sustained Release Tablets of Venlafaxine Resinates Using Response Surface Methodology
por: Madgulkar, Ashwini R., et al.
Publicado: (2009)

Formulation Design, Optimization and Pharmacodynamic Evaluation of Sustained Release Mucoadhesive Microcapsules of Venlafaxine HCl
por: Swain, S., et al.
Publicado: (2014)

The role of repetitive thinking and spirituality in the development of posttraumatic growth and symptoms of posttraumatic stress disorder
por: Eames, Catrin, et al.
Publicado: (2022)

A Multisite Randomized Controlled Trial of Mindfulness‐Based Stress Reduction in the Treatment of Posttraumatic Stress Disorder
por: Davis, Lori L., et al.
Publicado: (2018)

Uncontrolled Self-Medication with Venlafaxine in a Patient with Major Depressive Disorder
por: Song, Ji-Hye, et al.
Publicado: (2011)

Treatment patterns associated with Duloxetine and Venlafaxine use for Major Depressive Disorder
por: Ye, Wenyu, et al.
Publicado: (2011)

Venlafaxine-induced REM sleep behavioral disorder presenting as two fractures()
por: Ryan Williams, R., et al.
Publicado: (2017)

Evidence of symptom profiles consistent with posttraumatic stress disorder and complex posttraumatic stress disorder in different trauma samples
por: Elklit, Ask, et al.
Publicado: (2014)

Chronic treatment with agomelatine or venlafaxine reduces depolarization-evoked glutamate release from hippocampal synaptosomes
por: Milanese, Marco, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_mhaeioqk9dij7q0pe7kuju4sov